A series of novel functionalized mono -, bis - and tris- ( S )-{[(2 S ,4 R ,8 R )-8-ethyl-quinuclidin-2-yl](6-methoxyquinolin-4-yl)}methanamines including ferrocene-containing derivatives was obtained by the reaction of the precursor amine with a variety of acylation agents. Their in vitro antitumor activity was investigated against human leukemia (HL-60), human neuroblastoma (SH-SY5Y), human hepatoma (HepG2) and human breast cancer (MCF-7) cells by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-assay and the 50% inhibitory concentration (IC 50 ) values were determined. Our data indicate that the precursor amine has no antitumor activity in vitro , but the bis -methanamines with ureido-, thioureido and amide-type linkers display attractive in vitro cytotoxicity and cytostatic effects on HL-60, HepG2, MCF-7 and SH-SY5Y cells. Besides 1 H- and 13 C-NMR methods the structures of the new model compounds were also studied by DFT calculations.

No abstract

No abstract

No abstract

No abstract